United States · FDA National Drug Code directory
Aspercreme Lidocaine Foot (Diabetic)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 41167-0597_6e841df3-1b00-4aad-88d9-23844eb8891e
- Product NDC
- 41167-0597
- Form
- CREAM
- Composition / generic term
- LIDOCAINE HYDROCHLORIDE
- Labeler
- Chattem, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20180601
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 4 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (41167-0597-0) / 113 g in 1 BOTTLE, PLASTIC · 41167-0597-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →